Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2010 1
2011 4
2012 4
2013 1
2014 13
2015 20
2016 16
2017 18
2018 19
2019 9
2020 8
2021 5
2022 8
2023 5
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

123 results

Results by year

Filters applied: . Clear all
Page 1
CD25 gene polymorphism and multiple sclerosis.
Alsahebfosoul F, Salehi R, Ghaffari S, Jahanbani-Ardakani H, Etemadifar M, Kazemi M, Abtahi SH. Alsahebfosoul F, et al. Among authors: salehi r. Mult Scler Relat Disord. 2017 Nov;18:117-118. doi: 10.1016/j.msard.2017.09.005. Epub 2017 Sep 20. Mult Scler Relat Disord. 2017. PMID: 29141792 No abstract available.
Engaging stemness improves cancer immunotherapy.
Dianat-Moghadam H, Sharifi M, Salehi R, Keshavarz M, Shahgolzari M, Amoozgar Z. Dianat-Moghadam H, et al. Among authors: salehi r. Cancer Lett. 2023 Feb 1;554:216007. doi: 10.1016/j.canlet.2022.216007. Epub 2022 Nov 14. Cancer Lett. 2023. PMID: 36396102 Review.
Immunotherapies targeting tumor vasculature: challenges and opportunities.
Dianat-Moghadam H, Nedaeinia R, Keshavarz M, Azizi M, Kazemi M, Salehi R. Dianat-Moghadam H, et al. Among authors: salehi r. Front Immunol. 2023 Sep 1;14:1226360. doi: 10.3389/fimmu.2023.1226360. eCollection 2023. Front Immunol. 2023. PMID: 37727791 Free PMC article. Review.
SiRNA and epigenetic aberrations in ovarian cancer.
Mirzaei H, Yazdi F, Salehi R, Mirzaei HR. Mirzaei H, et al. Among authors: salehi r. J Cancer Res Ther. 2016 Apr-Jun;12(2):498-508. doi: 10.4103/0973-1482.153661. J Cancer Res Ther. 2016. PMID: 27461600 Free article. Review.
Molecular mechanisms of drug resistance in ovarian cancer.
Norouzi-Barough L, Sarookhani MR, Sharifi M, Moghbelinejad S, Jangjoo S, Salehi R. Norouzi-Barough L, et al. Among authors: salehi r. J Cell Physiol. 2018 Jun;233(6):4546-4562. doi: 10.1002/jcp.26289. Epub 2018 Jan 4. J Cell Physiol. 2018. PMID: 29152737 Review.
Epi-Drugs and Epi-miRs: Moving Beyond Current Cancer Therapies.
Salarinia R, Sahebkar A, Peyvandi M, Mirzaei HR, Jaafari MR, Riahi MM, Ebrahimnejad H, Nahand JS, Hadjati J, Asrami MO, Fadaei S, Salehi R, Mirzaei H. Salarinia R, et al. Among authors: salehi r. Curr Cancer Drug Targets. 2016;16(9):773-788. doi: 10.2174/1568009616666151207110143. Curr Cancer Drug Targets. 2016. PMID: 26638884 Review.
Distribution of CYP2D6 polymorphism in the Middle Eastern region.
Khalaj Z, Baratieh Z, Nikpour P, Khanahmad H, Mokarian F, Salehi R, Salehi M. Khalaj Z, et al. Among authors: salehi r. J Res Med Sci. 2019 Jul 24;24:61. doi: 10.4103/jrms.JRMS_1076_18. eCollection 2019. J Res Med Sci. 2019. PMID: 31523247 Free PMC article. Review.
Boron neutron capture therapy: Moving toward targeted cancer therapy.
Mirzaei HR, Sahebkar A, Salehi R, Nahand JS, Karimi E, Jaafari MR, Mirzaei H. Mirzaei HR, et al. Among authors: salehi r. J Cancer Res Ther. 2016 Apr-Jun;12(2):520-5. doi: 10.4103/0973-1482.176167. J Cancer Res Ther. 2016. PMID: 27461603 Free article. Review.
123 results